The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Cardiovascular risk factors in hypopituitary GH-deficient adults
Abstract
Design: Data on lipids, body composition, and blood pressure (BP) from all published KIMS papers are summarized and compared with a literature review. Results: KIMS data confirm and extend previous research showing that adults with GH deficiency (GHD) have an adverse cardiovascular risk profile. GHD patients have high levels of dyslipidemia, elevated body mass index, unfavorable waist-to-hip ratio and body composition, and a high risk of hypertension. These abnormalities are likely to explain the increased cardiovascular mortality observed in patients with hypopituitarism. When given GH replacement therapy, an improvement is seen in KIMS as well as earlier studies for lipid profile, body composition, and BP. The added value of the different KIMS papers over previous research is that KIMS involves a much larger number of patients, that lipid concentrations and IGF1 are measured in a single central laboratory, and that the effects of GH replacement therapy can be followed longer than the duration of earlier trials. By the large number of patients, KIMS gives insight into the effects of GH in different patients' subgroups such as elderly patients, patients with idiopathic GHD, patients with craniopharyngioma, patients after irradiation, and so on. In addition, KIMS has made it possible to calculate more exactly the influence of baseline parameters on these cardiovascular risk parameters and their response to GH. Conclusions: Taken together, data from KIMS confirm earlier knowledge about the important benefits of GH replacement therapy, but also on the use of GH in specific subgroups such as isolated GHD, patients above 65 years, and patients after irradiation. No subgroup yet has been identified as not responding well to GH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypopituitarism, in general, and GHD, in particular, are associated with a number of metabolic alterations (74 -79).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [78]
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475
Markussis, V., Beshyah, S. A., Johnston, D. G., Fisher, C., Nicolaides, A. N., & Sharp, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92892-j · Cited by 390
Maison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030840 · Cited by 362
Cardiovascular risk factors in adult patients with growth hormone deficiency
Rosén, T., Edén, S., Larson, G., Wilhelmsen, L., & Bengtsson, B.-Å. (1993) · Acta Endocrinologica · doi:10.1530/acta.0.1290195 · Cited by 338
Research works printed but not linked: 8
- Bates, 1996, Journal of Clinical Endocrinology & Metabolism, 81, 1169, 10.1210/jc.81.3.1169 · DOI · Paper page
- 1997, Journal of Clinical Endocrinology & Metabolism, 46, 75
- 1998, GROWTH HORMONE AND IGF RESEARCH, 8, 480
- 1994, ENDOCRINOLOGY AND METABOLISM, 1, 173
- Beshyah, 1995, Journal of Clinical Endocrinology & Metabolism, 80, 356, 10.1210/jc.80.2.356 · doi:10.1210/jc.80.2.356
- L nn, 1993, Basic life sciences, 60, 229
- 2000, JOURNAL OF CLINICAL ENDOCRINOLOGY, 85, 970
- 2005, Archives of physical medicine and rehabilitation, 3, 463
Cited by
The role of androgens and estrogens on healthy aging and longevity
Horstman, A. M., Dillon, E. L., Urban, R. J., & Sheffield-Moore, M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls068 · Cited by 396
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Wilkinson, C. W., Pagulayan, K. F., Petrie, E. C., Mayer, C. L., Colasurdo, E. A., Shofer, J. B., Hart, K. L., Hoff, D., Tarabochia, M. A., & Peskind, E. R. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00011 · Cited by 162
“…as adverse lipid profiles, increased blood pressure, abnormal body composition, increased body weight, increased coagulability, and increased markers of inflammation have all been shown to improve with GH replacement (Svensson et al., 2004a, 2007; Götherström et al., 2007a; Verhelst and Abs, 2009).”
BackgroundHamrahian, A. H., Yuen, K. C. J., Gordon, M. B., Pulaski-Liebert, K. J., Bena, J., & Biller, B. M. K. (2016) · Pituitary · doi:10.1007/s11102-016-0712-7 · Cited by 92
“In addition to the prevalence of obesity in the general population, hypopituitarism is associated with increased risk for obesity [25].”
BackgroundThe cardiovascular system in growth hormone excess and growth hormone deficiency.
(2012) · PubMed · doi:10.3275/8717 · Cited by 80
Metadata
- Authors
- Verhelst, J., & Abs, R.
- Affiliations
- ZNA Middelheim Hospital (BE)
- University of Antwerp (BE)
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 161
- Issue
- suppl_1
- Pages
- S41-S49
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2108282884
- Cited by
- 70
- References
- 70
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 12
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- growth hormone deficiency, hypopituitarism, cardiovascular risk factors, dyslipidemia, body composition, waist-to-hip ratio, hypertension, growth hormone replacement therapy, insulin-like growth factor I, elderly patients, craniopharyngioma, radiation effects, cardiovascular mortality
- MeSH terms
- Adult, Body Composition, Cardiovascular Diseases, Female, Humans, Hypertension, Hypopituitarism, Male, Risk Factors, Biomarkers, Body Mass Index, Databases, Factual, Risk Assessment, Human Growth Hormone, Waist-Hip Ratio, Dyslipidemias, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular risk factors in hypopituitary GH-deficient adults. https://app.cochat.ai/papers/10.1530/eje-09-0291
- The paper
- Verhelst, J., & Abs, R. (2009). Cardiovascular risk factors in hypopituitary GH-deficient adults. European Journal of Endocrinology. https://doi.org/10.1530/eje-09-0291
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.